Cause of rare, fatal disorder in young children pinpointed
Scientists at the School of Medicine have pinpointed the precise cause of Krabbe disease, a neurodegenerative condition that usually causes death by age 3.
Radiation therapy effective against deadly heart rhythm
A single high dose of radiation aimed at the heart significantly reduces episodes of a potentially deadly rapid heart rhythm, according to results of a phase one/two study at the School of Medicine.
Medical student receives fellowship to study degenerative arthritis
Dongyeon “Joanna” Kim, a second-year medical student at the School of Medicine, is one of 50 recipients of a $5,000 summer research fellowship from the Alpha Omega Alpha National Honor Medical Society. Kim is researching osteoarthritis, a common, degenerative joint disease that afflicts tens of millions of adults nationwide.
$5 million grant endows research to advance blood disorder therapies
The School of Medicine has received a $5 million grant from the Edward P. Evans Foundation to establish and endow a new center focused on advancing research and improving treatments for a rare set of blood disorders called myelodysplastic syndromes, or MDS, that leaves the body unable to make enough healthy blood cells.
Hallahan named a National Academy of Inventors senior member
Radiation oncologist Dennis E. Hallahan, MD, of the School of Medicine, has been elected a senior member of the National Academy of Inventors. Hallahan is the Elizabeth H. and James S. McDonnell III Distinguished Professor of Medicine and head of the Department of Radiation Oncology.
Halting spread of HIV in Midwest is aim of new network
As part of a federal initiative to end the HIV epidemic, Washington University in St. Louis will establish a center to provide guidance and support to local organizations working to reduce HIV infection rates in their communities. Among other things, the center will help organizations provide PrEP, a medicine that prevents HIV infection.
$7.5 million to fund pioneering approaches to respiratory disease
Michael J. Holtzman, MD, director of the School of Medicine’s Division of Pulmonary & Critical Care Medicine, has received awards totaling $7.5 million to support innovative research aimed at defining and controlling chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease.
Big Idea: Cortex
Welcome to Cortex, an innovation community started in 2002 thanks to a lead investment from Washington University. Drone footage takes you through the formerly blighted industrial complex that is now a hip mixed-use space and home to more than 5,800 jobs. This is Cortex.
Use of antibiotics in preemies has lasting, potentially harmful effects
Nearly all babies born prematurely receive antibiotics. A new study from the School of Medicine suggests that such early antibiotic treatment could have long-lasting and potentially harmful effects on the gut microbiome.
Mattar named a chair of group aimed at combating antimicrobial resistance
Caline Mattar, MD, assistant professor of medicine in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis, has been appointed a chair of the Expert Advisory Group for the Global Antimicrobial Resistance Research and Development Hub.
View More Stories